Capital Investment Advisory Services’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,860
Closed -$245K 787
2021
Q1
$245K Sell
1,860
-100
-5% -$13.7K 0.03% 371
2020
Q4
$260K Hold
1,960
0.04% 362
2020
Q3
$200K Sell
1,960
-4,100
-68% -$354K 0.04% 359
2020
Q2
$527K Sell
6,060
-100
-2% -$7.99K 0.11% 175
2020
Q1
$357K Sell
6,160
-1,600
-21% -$130K 0.09% 207
2019
Q4
$718K Sell
7,760
-100
-1% -$8.79K 0.19% 118
2019
Q3
$710K Buy
7,860
+425
+6% +$48.4K 0.2% 102
2019
Q2
$863K Buy
+7,435
New +$749K 0.26% 79

Other funds holding EXAS

Capital Investment Advisory Services's EXAS Position: Q2 2021 in Review

Capital Investment Advisory Services sold out of Exact Sciences (EXAS) in Q2 2021, closing a stake of 1,860 shares — an estimated $245K sold.

Capital Investment Advisory Services first reported a position in EXAS in Q2 2019 and held it in 8 quarters. The position peaked at $863K in Q2 2019. 623 funds tracked by Wall St. Rank hold EXAS as of Q2 2021.

  • Capital Investment Advisory Services reported no remaining Exact Sciences position as of Q2 2021 after selling out during the quarter.
  • Capital Investment Advisory Services sold 1,860 Exact Sciences shares in Q2 2021, an estimated $245K.
  • Capital Investment Advisory Services first reported a position in Exact Sciences in Q2 2019 and held it in 8 quarters.
  • Capital Investment Advisory Services's Exact Sciences position peaked at $863K in Q2 2019.
  • 623 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2021.

Based on Capital Investment Advisory Services's 13F filing for Q2 2021, filed 27 Jul 2021.